IMP
Process View
negative regulation of response to oxidative stress
Any process that stops, prevents or reduces the frequency, rate or extent of response to oxidative stress.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of response to oxidative stress"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TRIB3 | tribbles homolog 3 (Drosophila) | 0.892 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.890 | ||
| SFPQ | splicing factor proline/glutamine-rich | 0.767 | Human | |
| MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.573 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.239 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.227 | ||
| GAS6 | growth arrest-specific 6 | 0.214 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.214 | ||
| FTL | ferritin, light polypeptide | 0.152 | ||
| NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.141 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.140 | ||
| ZNF746 | zinc finger protein 746 | 0.138 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.115 | ||
| TOP1 | topoisomerase (DNA) I | 0.114 | ||
| FUS | fused in sarcoma | 0.108 | ||
| WBP4 | WW domain binding protein 4 (formin binding protein 21) | 0.105 | ||
| CTSD | cathepsin D | 0.084 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.078 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.078 | ||
| KEAP1 | kelch-like ECH-associated protein 1 | 0.075 | ||
| FBXO7 | F-box protein 7 | 0.075 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.066 | ||
| EED | embryonic ectoderm development | 0.064 | ||
| PRDX1 | peroxiredoxin 1 | 0.058 | ||
| PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.056 | ||
| PINK1 | PTEN induced putative kinase 1 | 0.056 | ||
| APOE | apolipoprotein E | 0.054 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.046 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.046 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.041 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.040 | ||
| MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.039 | ||
| HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 0.036 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.035 | ||
| PLXNB1 | plexin B1 | 0.031 | ||
| HSPB8 | heat shock 22kDa protein 8 | 0.031 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.030 | ||
| EWSR1 | Ewing sarcoma breakpoint region 1 | 0.028 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.027 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.027 | ||
| CRYAB | crystallin, alpha B | 0.026 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.026 | Human | |
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.024 | ||
| HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.024 | ||
| LAT | linker for activation of T cells | 0.024 | ||
| DYNLL1 | dynein, light chain, LC8-type 1 | 0.022 | ||
| SQSTM1 | sequestosome 1 | 0.021 | ||
| BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.020 | Human | |
| MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.020 | ||
| EFTUD2 | elongation factor Tu GTP binding domain containing 2 | 0.020 | ||
| SSX4 | synovial sarcoma, X breakpoint 4 | 0.019 | ||
| APOA1 | apolipoprotein A-I | 0.019 | ||
| NFE2L1 | nuclear factor (erythroid-derived 2)-like 1 | 0.019 | Human | |
| SMAD2 | SMAD family member 2 | 0.018 | ||
| ZBED1 | zinc finger, BED-type containing 1 | 0.018 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.018 | ||
| OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin | 0.017 | ||
| PRKCZ | protein kinase C, zeta | 0.017 | ||
| SLC25A6 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | 0.017 | ||
| RAB5B | RAB5B, member RAS oncogene family | 0.016 | ||
| APLP2 | amyloid beta (A4) precursor-like protein 2 | 0.016 | ||
| HDAC1 | histone deacetylase 1 | 0.015 | ||
| COX7A2 | cytochrome c oxidase subunit VIIa polypeptide 2 (liver) | 0.015 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.013 | ||
| NONO | non-POU domain containing, octamer-binding | 0.013 | ||
| KNG1 | kininogen 1 | 0.013 | ||
| ZMYM2 | zinc finger, MYM-type 2 | 0.013 | ||
| MEF2C | myocyte enhancer factor 2C | 0.012 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.012 | ||
| CTSL1 | cathepsin L1 | 0.012 | ||
| AHR | aryl hydrocarbon receptor | 0.012 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.012 | ||
| FOXO3 | forkhead box O3 | 0.012 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.012 | ||
| RCOR1 | REST corepressor 1 | 0.012 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.012 | ||
| CRYAA | crystallin, alpha A | 0.012 | ||
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.011 | ||
| MAP1B | microtubule-associated protein 1B | 0.011 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.011 | ||
| ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 0.011 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.011 | ||
| SIAH1 | seven in absentia homolog 1 (Drosophila) | 0.010 | ||
| PACRG | PARK2 co-regulated | 0.010 | ||
| APOC1 | apolipoprotein C-I | 0.010 | ||
| OTUD4 | OTU domain containing 4 | 0.010 |